Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara H Rath

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
The Olfactory Bulb Provides a Radioresistant Niche for Glioblastoma CellsCindy R Timme, Charlotte Degorre-Kerbaul, Joseph H McAbee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2013
The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cellsThomas J Hayman, Amy Wahba, Barbara H Rath, et al.
Cancer Research|October 17, 2019
Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like CellsJoseph H McAbee, Barbara H Rath, Kristin Valdez, et al.
Nucleic Acids Research|December 12, 2019
53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapyIris Eke, Dali Zong, Molykutty J Aryankalayil, et al.
Stem Cell Reviews and Reports|February 27, 2010
Laser-assisted photoablation of human pluripotent stem cells from differentiating culturesStefanie Terstegge, Franziska Winter, Barbara H Rath, et al.
Molecular Cancer Therapeutics|August 13, 2017
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an ExampleIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
Annals of Neurology|August 10, 2010
Residual tumor cells are unique cellular targets in glioblastomaMartin Glas, Barbara H Rath, Matthias Simon, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
The Olfactory Bulb Provides a Radioresistant Niche for Glioblastoma CellsCindy R Timme, Charlotte Degorre-Kerbaul, Joseph H McAbee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2013
The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cellsThomas J Hayman, Amy Wahba, Barbara H Rath, et al.
Cancer Research|October 17, 2019
Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like CellsJoseph H McAbee, Barbara H Rath, Kristin Valdez, et al.
Nucleic Acids Research|December 12, 2019
53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapyIris Eke, Dali Zong, Molykutty J Aryankalayil, et al.
Stem Cell Reviews and Reports|February 27, 2010
Laser-assisted photoablation of human pluripotent stem cells from differentiating culturesStefanie Terstegge, Franziska Winter, Barbara H Rath, et al.
Molecular Cancer Therapeutics|August 13, 2017
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an ExampleIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
Annals of Neurology|August 10, 2010
Residual tumor cells are unique cellular targets in glioblastomaMartin Glas, Barbara H Rath, Matthias Simon, et al.
Pageof 2